Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors

被引:23
作者
Komorowicz, E [1 ]
Kolev, K [1 ]
Machovich, R [1 ]
机构
[1] Semmelweis Univ Med, Dept Med Biochem, H-1088 Budapest, Hungary
关键词
D O I
10.1021/bi980180d
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Quantitative characterization of the interaction of des-kringle(1-5)-plasmin (microplasmin) with fibrin(ogen) and plasma protease inhibitors may serve as a tool for further evaluation of the role of kringle domains in the regulation of fibrinolysis. Comparison of fibrin(ogen) degradation products yielded by plasmin, miniplasmin (des-kringle(1-4)-plasmin), microplasmin, and trypsin on SDS gel electrophoresis indicates that the differences in the enzyme structure result in different rates of product formation, whereas the products of the four proteases are very similar in molecular weight. Kinetic parameters show that plasmin is the most efficient enzyme in fibrinogen degradation, and the k(cat)/K-M ratio decreases in parallel with the loss of the kringle domains. The catalytic sites of the four proteases have similar affinities for fibrin (K-M values between 0.12 and 0.21 mu M). Trypsin has the highest catalytic constant for fibrin digestion (k(cat) = 0.47 s(-1)), and among plasmins with different kringle structures, the loss of kringle(5) results in a markedly lower catalytic rate constant (k(cat) = 0.0076 s(-1) for microplasmin vs 0.048 s(-1) for miniplasmin and 0.064 s(-1) for plasmin). In addition, microplasmin is inactivated by plasmin inhibitor (k " = 3.9 x 10(5) M-1 s(-1)) and antithrombin (k " = 1.4 x 10(3) M-1 s(-1)) and the rate of inactivation decreases in the presence of fibrin(ogen). Heparin (250 nM) accelerates the inactivation of microplasmin by antithrombin (k " = 10.5 x 10(3) M-1 s(-1)), whereas that by plasmin inhibitor is not affected (k " = 4.2 x 10(5) M-1 s(-1)).
引用
收藏
页码:9112 / 9118
页数:7
相关论文
共 45 条
[1]  
Bachmann F., 1994, HEMOSTASIS THROMBOSI, V3rd, P1592
[2]   STUDIES ON DEGRADATION OF HUMAN FIBRINOGEN BY PLASMIN AND TRYPSIN [J].
BECK, EA ;
JACKSON, DP .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1966, 16 (3-4) :526-&
[3]   Differential effects of lys- and mini-plasminogen on clot lysis induced by recombinant urokinase and recombinant pro-urokinase in a canine thrombosis model [J].
Burke, SE ;
Davidson, DJ ;
Lubbers, NL ;
Reininger, IM ;
Henkin, J .
THROMBOSIS RESEARCH, 1996, 83 (06) :421-431
[4]   POSITIVE COOPERATIVE BINDING AT 2 WEAK LYSINE-BINDING SITES GOVERNS THE GLU-PLASMINOGEN CONFORMATIONAL CHANGE [J].
CHRISTENSEN, U ;
MOLGAARD, L .
BIOCHEMICAL JOURNAL, 1992, 285 :419-425
[6]   PLASMINOGEN - PURIFICATION FROM HUMAN PLASMA BY AFFINITY CHROMATOGRAPHY [J].
DEUTSCH, DG ;
MERTZ, ET .
SCIENCE, 1970, 170 (3962) :1095-+
[7]  
EVERSE SJ, 1995, PROTEIN SCI, V4, P1013
[8]   CHARACTERIZATION OF THE BINDING OF PLASMINOGEN TO FIBRIN SURFACES - THE ROLE OF CARBOXY-TERMINAL LYSINES [J].
FLEURY, V ;
ANGLESCANO, E .
BIOCHEMISTRY, 1991, 30 (30) :7630-7638
[9]   MOLECULAR-CLONING AND CHARACTERIZATION OF A FULL-LENGTH CDNA CLONE FOR HUMAN-PLASMINOGEN [J].
FORSGREN, M ;
RADEN, B ;
ISRAELSSON, M ;
LARSSON, K ;
HEDEN, LO .
FEBS LETTERS, 1987, 213 (02) :254-260
[10]   HEPARIN MODULATION OF THE FIBRINOLYTIC-ACTIVITY OF PLASMIN, MINIPLASMIN AND NEUTROPHIL LEUKOCYTE ELASTASE IN THE PRESENCE OF PLASMA PROTEASE INHIBITORS [J].
KOLEV, K ;
KOMOROWICZ, E ;
MACHOVICH, R .
BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (06) :905-911